To receive continuing education (CE) credit, you must complete the virtual lecture, posttest and activity evaluation.
1.0 CE Credit Available Until: August 5, 2020
Pediatricians, family physicians, oncologists, physician assistants, nurse practitioners, nurses, and oncology social workers at the intermediate and advanced levels involved in the care of patients with hematologic malignancies.
At the conclusion of this program, participants will be able to:
- Describe childhood blood cancers, including ALL, AML, and rare lymphomas such as Burkitt.
- Identify signs and symptoms of childhood blood cancer and diagnostic tests.
- Assess appropriate referral to a pediatric hematologist-oncologist and patient care during and post-cancer treatment.
- Explain treatments, including the role of clinical trials, and management of short- and long-term side effects.
Susan R. Rheingold, MD
Medical Director, Oncology Outpatient Clinic
Cancer Center at Children’s Hospital of Philadelphia
Professor of Clinical Pediatrics
University of Pennsylvania
Bradley J. Dyer, MD, FAAP
Founder, All Star Pediatrics
Jointly provided by The Leukemia & Lymphoma Society and Clinical Directors Network, Inc.
Sponsors and Supports:
This activity is supported by The Leukemia & Lymphoma Society and Clinical Directors Network, Inc.